VIR
Vir Biotechnology, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones -4.5% · nuevas posiciones netas 0.0% · fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 20.43K | $227,193 | n/a | n/a |
| Q2 2026 | 87 | -1 | 78.79M | $802.94M | +8 | −9 |
| Q1 2026 | 91 | +1 | 69.76M | $624.09M | +9 | −8 |
| Q4 2025 | 90 | +1 | 66.65M | $401.74M | +1 | n/a |
| Q3 2025 | 15 | 0 | 49.25M | $281.20M | n/a | n/a |
| Q2 2025 | 12 | 0 | 46.48M | $234.27M | n/a | n/a |
| Q1 2025 | 9 | -2 | 12.32M | $79.81M | n/a | −2 |
| Q4 2024 | 11 | 0 | 12.20M | $89.54M | +1 | −1 |
| Q3 2024 | 10 | -2 | 8.42M | $63.10M | n/a | −2 |
| Q2 2024 | 12 | n/a | 10.84M | $96.49M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 15.97M | -1.1% | $91.18M | 0.0% | ▼ Trim | 2 | SEC ↗ ×15 |
| 2 | The Vanguard Group ✦ (pasivo) | 12.80M | -3.2% | $73.08M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (pasivo) | 5.24M | -0.3% | $29.93M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 3.64M | +2.2% | $20.77M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 5 | Morgan Stanley ✦ | 2.69M | n/a | $15.35M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 6 | Geode Capital Management ✦ (pasivo) | 2.25M | -0.3% | $12.83M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 7 | Goldman Sachs Group ✦ | 1.52M | n/a | $8.69M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 8 | Millennium Management ✦ | 1.40M | +129.2% | $7.97M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 9 | Renaissance Technologies ✦ | 1.17M | +9.6% | $6.66M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 10 | JPMorgan Chase ✦ | 899.04K | n/a | $5.13M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 11 | Citadel Advisors ✦ | 799.03K | -76.9% | $4.56M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 12 | Two Sigma Investments ✦ | 649.30K | +75.7% | $3.71M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 152.14K | -66.1% | $868,705 | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 14 | T. Rowe Price ✦ | 47.14K | +9.8% | $270,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 33.52K | -7.5% | $191,422 | 0.0% | ▼ Trim | 6 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 251 tenedores, 138.04M acciones, $1.23B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.